Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats

Ladislavová Lucie, Kútná Viera, Mazochová Kristýna, Šíchová Klára, Danda Hynek, Lhotková Eva, Uttl Libor, Brejtr Vojtěch, Syrová Kateřina, Mazoch Vladimír, Horsley Rachel, Páleníček Tomáš

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (53)

  1. Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticity. 2026-02-01 · Expand citations
  2. Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression. 2025-07-01 · Expand citations
  3. Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms. 2024-10-01 · Expand citations
  4. Effects of psilocybin on uncertain punishment learning. 2024-09-01 · Expand citations
  5. Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice. 2024-05-01 · Expand citations
  6. Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity. 2023-12-20 · Expand citations
  7. Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats. 2023-09-01 · Expand citations
  8. Towards an understanding of psychedelic-induced neuroplasticity. 2023-01-01 · Expand citations
  9. Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice. 2022-11-11 · Expand citations
  10. Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice. 2022-08-11 · Expand citations
  11. Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study. 2022-08-02 · Expand citations
  12. Validation of the forced swim test in Drosophila, and its use to demonstrate psilocybin has long-lasting antidepressant-like effects in flies. 2022-06-15 · Expand citations
  13. A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT Receptor Density in the Pig Brain. 2021-01-15 · Expand citations
  14. Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property. 2021-01-01 · Expand citations
  15. Microdosing psychedelics: Motivations, subjective effects and harm reduction. 2020-01-01 · Expand citations
  16. Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat. 2019-08-01 · Expand citations
  17. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. 2018-02-01 · Expand citations
  18. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. 2016-07-01 · Expand citations
  19. Sex differences and serotonergic mechanisms in the behavioural effects of psilocin 2016-06-01 · Expand citations
  20. Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning. 2013-08-01 · Expand citations
  21. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
  22. 10.1007/bf00421184
  23. 10.1007/bf02245592
  24. 10.1007/s00213-004-2048-7
  25. 10.1007/s002130000514
  26. 10.1007/s002130051156
  27. 10.1007/s12640-020-00297-8
  28. 10.1016/0006-8993(78)91021-1
  29. 10.1016/0024-3205(95)02242-9
  30. 10.1016/0166-4328(95)00203-0
  31. 10.1016/j.cell.2016.10.021
  32. 10.1016/j.celrep.2018.05.022
  33. 10.1016/j.celrep.2021.109836
  34. 10.1016/j.expneurol.2022.114148
  35. 10.1016/j.neubiorev.2005.04.017
  36. 10.1016/j.pnpbp.2015.06.017
  37. 10.1016/j.psyneuen.2007.02.012
  38. 10.1016/s0014-2999(03)01273-1
  39. 10.1016/s0014-2999(98)00223-4
  40. 10.1016/s0165-6147(02)02017-5
  41. 10.1021/acschemneuro.8b00692
  42. 10.1038/nprot.2007.44
  43. 10.1038/nprot.2012.044
  44. 10.1038/s41380-024-02655-w
  45. 10.1038/s41386-021-01091-6
  46. 10.1101/cshperspect.a018812
  47. 10.1111/adb.13216
  48. 10.1126/sciadv.adl6554
  49. 10.1126/scitranslmed.aaw6435
  50. 10.1177/02698811221089039
  51. 10.1242/dev.00203
  52. 10.1371/journal.pone.0211023
  53. 10.3389/fnbeh.2015.00223

Cited by — these papers cite this paper (0)

No citing papers identified in the available metadata. This does not establish that none exist.